17
Views
15
CrossRef citations to date
0
Altmetric
Research Article

In Vivo Characterization and Modulation of the Glutathione/Glutathione S-Transferase System in Cancer Patients

, , &
Pages 191-229 | Published online: 22 Sep 2008

References

  • Ketterer B., Mulder G. J. Glutathione conjugation. Conjugation Reactions in Drug Metabolism, G. J. Mulder. Taylor and Francis. 1990; 307–364
  • DeLeve L. D., Kaplowitz N. Glutathione metabolism and its role in hepatotoxicity. Pharmac. Ther. 1991; 52: 287–305
  • Potter D. W., Tran T. B. Apparent rates of glutathione turnover in rat tissues. Toxicol. Appl. Pharmacol. 1993; 120: 186–192
  • Meister A. Glutathione. The Liver: Biology and Pathobiology 2nd ed., I. M. Arias, W. B. Jakoby, H. Popper, D. Schachter, D. A. Shafritz. Raven Press, New York 1988; 401–417
  • Mannervik B., Alin P., Guthenberg C., Jensson H., Tahir M. K., Warholm M., Jornvall H. Identification of three classes of cytosolic glutathione transferase common to several mammalian species: Correlation between structural data and enzymatic properties. Proc. Natl. Acad. Sci. USA 1985; 82: 7202–7206
  • Mannervick B., Awasthi Y. C., Board P. G., Hayes J. D., DiIlio C., Ketterer B., Listowsky I., Morgenstern R., Muramatsu M., Pearson W. R., Pickett C. B., Sato K., Widersten M., Wolf C. R. Nomenclature for human glutathione transferases. Biochem. J. 1992; 282: 305–308
  • Board P., Coggan M., Johnston P., Ross V., Suzuki T., Webb G. Genetic heterogeneity of the human glutathione transferases: A complex of gene families. Pharmac. Ther. 1990; 48: 357–369
  • Meyer D. J., Coles B., Pemble S. E., Gilmore K. S., Fraser G. M., Ketterer B. Theta, a new class of glutathione transferases purified from rat and man. Biochem. J. 1991; 274: 409–414
  • Monks T. J., Anders M. W., Dekant W., Stevens J. L., Lau S. S., van Bladeren P. J. Contemporary issues in toxicology: Glutathione conjugate mediated toxicities. Toxicol. Appl. Pharmacol 1990; 106: 1–19
  • Koob M., Dekant W. Bioactivation of xenobiotics by formation of toxic glutathione conjugates. Chem.-Biol. Interact. 1991; 77: 107–136
  • Listowsky I. Glutathione-5-transferases: Intracellular binding, detoxification, and adaptive responses. Hepatic Transport and Bile Secretion: Physiology and Pathophysiology, N. Tavoloni, P. D. Berk. Raven Press, New York 1993; 397–405
  • van Ommen B., Bogaards J. J. P., Peters W. H. M., Blaauboer B., van Bladeren P. J. Quantification of human hepatic glutathione 5-transferases. Biochem. J. 1990; 269: 609–613
  • Peters W. H. M., Roelofs H. M. J., Nagengast F. M., van Tongeren J. H. M. Human intestinal glutathione 5-transferases. Biochem. J. 1989; 257: 471–476
  • Peters W. H. M., Kock L., Nagengast F. M., Kremers P. G. Biotransformation enzymes in human intestine: Critical low levels in the colon?. Gut 1991; 32: 408–412
  • Tsuchida S., Sato K. Glutathione transferases and cancer. Bio-chem. Mol. Biol. 1992; 27: 337–384
  • Seidegård J., Pero R. W. The hereditary transmission of high glutathione transferase activity towards tranS-stilbene oxide in human mononuclear leucocytes. Hum. Genet. 1985; 69: 66–68
  • Seidegård J., Vorachek W. R., Pero R. W., Pearson W. R. Hereditary differences in the expression of the human glutathione transferase active on franS-stilbene oxide are due to a gene deletion. Proc. Natl. Acad. Sci. USA 1988; 85: 7293–7297
  • Hussey A. J., Hayes J. D., Beckett G. J. The polymorphic expression of neutral glutathione S-transferase in human mononuclear leucocytes as measured by specific radioimmunoassay. Biochem. Pharmacol. 1987; 36: 4013–4015
  • Mulders T. M. T., Venizelos V., Schoemaker R., Cohen A. F., Breimer D. D., Mulder G. J. Characterization of glutathione conjugation in humans: Stereoselectivity in plasma elimination pharmacokinetics and urinary excretion of (R)- and (S)-2-bromoiso-valerylurea in healthy volunteers. Clin. Pharmacol. Ther. 1993; 53: 49–58
  • Tietze F. Enzymic method for quantitative determination of nanogram amounts of total and oxidised glutathione: Applications to mammalian blood and other tissues. Anal. Biochem. 1969; 27: 502–522
  • Svardal A. M., Mansoor M. A., Ueland P. M. Determination of reduced, oxidized, and protein-bound glutathione in human plasma with precolumn derivatization with monobromobimane and liquid chromatography. Anal. Biochem. 1990; 184: 338–346
  • Mansoor M. A., Svardal A. M., Ueland P. M. Determination of the in vivo redox status of cysteine, cysteinylglycine, homocysteine, and glutathione in human plasma. Anal. Biochem. 1992; 200: 218–229
  • Slordal L., Andersen A., Dajani L., Warren D. J. A simple HPLC method for the determination of cellular glutathione. Pharmacol. Toxicol. 1993; 73: 124–126
  • Cook J. A., Iype S. N., Mitchell J. B. Differential specificity of monochlorobimane for isoenzymes of human and rodent glutathione S-transferases. Cancer Res. 1991; 51: 1606–1612
  • Ublacker G. A., Johnson J. A., Siegel F. L., Mulcahy R. T. Influence of glutathione S-transferases on cellular glutathione determination by flow cytometry using monochlorobimane. Cancer Res. 1991; 51: 1783–1788
  • Martin J., White I. N. H. Fluorometric determination of oxidised and reduced glutathione in cells and tissues by high-performance liquid chromatography following derivatization with dansyl chloride. J. Chromatogr. 1991; 568: 219–225
  • Harvey P. R. C., Ilson R. G., Strasberg S. M. The simultaneous determination of oxidized and reduced glutathione in liver tissue by ion pairing reverse phase high performance liquid chromatography with a coulometric electrochemical detector. Clin. Chim. Acta 1989; 180: 203–212
  • Øzcimder M., Louter A. J. H., Lingeman H., Voogt W. H., Frei R. W., Bloemendal M. Determination of oxidized, reduced and protein-bound glutathione in eye lenses by high-performance liquid chromatography and electrochemical detection. J. Chromatogr. 1991; 570: 19–28
  • Morier-Teissier E., Mestdagh N., Bernier J. L., Heni-chart J. P. Reduced and oxidized glutathione ratio in tumor cells: Comparison of two measurement methods using HPLC and electrochemical detection. J. Liquid Chromatogr. 1993; 16: 573–596
  • Mills B. J., Richie J. P., Lang C. A. Sample processing alters glutathione and cysteine values in blood. Anal. Biochem. 1990; 184: 263–267
  • Schofield D., Braganza J. M. Difficulties in measuring oxidized glutathione in biological samples. Clin. Sci. 1992; 82: 117–118
  • Schofield D., Mei G., Braganza J. M. Some pitfalls in the measurement of blood glutathione. Clin. Sci. 1993; 85: 213–208
  • Roberts J. C., Francetic D. J. The importance of sample preparation and storage in glutathione analysis. Anal. Biochem. 1993; 211: 183–187
  • Adams J. D., Lauterburg B. H., Mitchell J. R. Plasma glutathione and glutathione disulfide in the rat: Regulation and response to oxidative stress. J. Pharmacol. Exp. Ther. 1983; 227: 749–754
  • Shigesawa T., Sato C., Marumo F. Significance of plasma glutathione determination in patients with alcoholic and non-alcoholic liver disease. J. Gastroenterol. Hepatol. 1992; 7: 7–11
  • Mannervick B. The isoenzymes of glutathione transferase. Adv. Enzymol. Rel. Areas Mol. Biol. 1985; 57: 357–417
  • Castro V. M., Soderstrom M., Carlberg I., Widersten M., Platz A., Mannervik B. Differences among human tumor cell lines in the expression of glutathione transferases and other glutathione-linked enzymes. Carcinogenesis 1990; 11: 1569–1576
  • Shea T. C., Claflin G., Comstock K. E., Sanderson B. J. S., Burstein N. A., Keenan E. J., Mannervik B., Henner W. D. Glutathione transferase activity and isoenzyme composition in primary human breast cancers. Cancer Res. 1990; 50: 6848–6853
  • Clapper M. L., Hoffman S. J., Tew K. D. Glutathione S-transferases in normal and malignant human colon tissue. Biochitn. Biophys. Acta 1991; 1096: 209–216
  • Singh S. V., Roberts B., Gudi V. A., Ruiz P., Awasthi Y. C. Immunohistochemical localization, purification and characterization of human urinary bladder glutathione S-transferases. Biochim. Biophys. Acta 1991; 1074: 363–370
  • Schisselbauer J. C., Hogan W. M., Buetow K. H., Tew K. D. Heterogeneity of glutathione S-transferase enzyme and gene expression in ovarian carcinoma. Pharmacogenetics 1992; 2: 63–72
  • Albin N., Massaad L., Toussaint C., Matthieu M. C., Morizet J., Parise O., Gouyette A., Chabot G. G. Main drug-metabolizing enzyme systems in human breast tumors and peritumoral tissues. Cancer Res. 1993; 53: 3541–3546
  • Klöne A., Weidner U., Hußnätter R., Harris J., Meyer D., Peter S., Ketterer B., Sies H. Decreased expression of the glutathione S-transferases alpha and pi genes in human renal cell carcinoma. Carcinogenesis 1990; 11: 2179–2183
  • Strohmeyer T., Klöne A., Wagner G., Hartmann M., Sies H. Glutathione S-transferases in human testicular germ cell tumors: Changes of expression and activity. J. Urol. 1992; 147: 1424–1428
  • Linsenmeyer M. E., Jefferson S., Wolf M., Matthews J. P., Board P. G., Woodcock D. M. Levels of expression of the mdrl gene and glutathione S-transferase genes 2 and 3 and response to chemotherapy in multiple myeloma. Br. J. Cancer 1992; 65: 471–475
  • Sasano H., Miuazaki S., Shiga K., Goukon Y., Nishihira T., Nagura H. Glutathione S-transferase in human esophageal carcinoma. Anticancer Res. 1993; 13: 363–368
  • Habig W. H., Pabst M. J., Jakoby W. B. Glutathione S-transferases, the first step in mercapturic acid formation. J. Biol. Chem. 1974; 249: 7130–7139
  • Ploemen J. H. T. M., van Ommen B., van Bladeren P. J. Inhibition of rat and human glutathione S-transferase isoenzymes by ethacrynic acid and its glutathione conjugate. Biochem. Pharmacol. 1990; 40: 1631–1635
  • Ploemen J. H. T. M., Bogaards J. J. P., Velding G. A., van Ommen B., Jansen D. H. M., van Bladeren P. J. Isoenzyme selective irreversible inhibition of rat and human glutathione 5-tranS-ferases by ethacrynic acid and two brominated derivatives. Biochem. Pharmacol. 1993; 45: 633–639
  • Seidegård J., Pero R. W., Miller D. G., Beattie E. J. A glutathione transferase in human leukocytes as a marker for the susceptibility to lung cancer. Carcinogenesis 1986; 7: 751–753
  • Seidegård J., Pero R. W., Markowitz M. M., Roush G., Miller D. G., Beattie E. J. Isoenzyme(s) of glutathione transferase (class mu) as a marker for the susceptibility to lung cancer: A follow up study. Carcinogenesis 1990; 11: 33–36
  • Zhong S., Howie A. F., Ketterer B., Taylor J., Hayes J. D., Beckett G. J., Wathen C. G., Wolf C. R., Spurr N. K. Glutathione 5-transferase mu locus: Use of genotyping and phenotyping assays to assess association with lung cancer susceptibility. Carcinogenesis 1991; 12: 1533–1537
  • Brockmöller J., Gross D., Kerb R., Drakoulis N., Roots I. Correlation between tranS-stilbene oxide-glutathione conjugation activity and the deletion mutation in the glutathione 5-transferase class mu gene detected by polymerase chain reaction. Biochem. Pharmacol. 1992; 43: 647–650
  • Brockmöller J, Kerb R., Drakoulis N., Nitz M., Roots I. Genotype and phenotype of glutathione 5-transferase class μ isoenzymes μ and ϕ in lung cancer patients and controls. Cancer Res. 1993; 53: 1004–1011
  • Hayashi S., Watanabe J., Kawajiri K. High susceptibility to lung cancer analyzed in terms of combined genotypes of P4501A1 and mu-class glutathione 5-transferase genes. Jpn. J. Cancer Res. 1992; 83: 866–870
  • Heckbert S. R., Weiss N. S., Hornung S. K., Eaton D. L., Motulsky A. G. Glutathione 5-transferase and epoxide hydrolase activity in human leukocytes in relation to risk of lung cancer and other smoking-related cancers. J. Natl. Cancer Inst. 1992; 84: 414–422
  • Bell D. A., Taylor J. A., Paulson D. F., Robertson C. N., Mohler J. L., Lucier G. W. Genetic risk and carcinogen exposure: A common inherited defect of the carcinogen-metabolism gene glutathione 5-transferase Ml (GSTM1) that increases susceptibility to bladder cancer. J. Natl. Cancer Inst. 1993; 85: 1159–1164
  • Nazar-Stewart V., Motulsky A. G., Eaton D. L., White E., Hornung S. K., Leng Z. T., Stapleton P., Weiss N. S. The glutathione 5-transferase n polymorphism as a marker for susceptibility to lung carcinoma. Cancer Res. 1993; 53: 2313–2318
  • Seidegård J., Guthenberg C., Pero R. W., Mannervik B. The TranS-stilbene oxide-active glutathione transferase in human mononuclear leucocytes is identical with the hepatic glutathione transferase μ. Biochem. J. 1987; 246: 783–785
  • Peters W. H. M., Kock L., Nagengast F. M., Roelofs H. M. J. Immunodetection with a monoclonal antibody of glutathione S-transferase mu in patients with and without carcinomas. Biochem. Pharmacol. 1990; 39: 591–597
  • Liu Y. H., Taylor J., Linko P., Lucier G. W., Thompson C. L. Glutathione S-transferase μ in human lymphocyte and liver: Role in modulating formation of carcinogen-derived DNA adducts. Carcinogenesis 1991; 12: 2269–2275
  • Roots I., Brockmöller J., Drakoulis N., Loddenkemper R. Mutant genes of cytochrome P-450IID6, glutathione S-transferase class mu, and arylamine N-acetyltransferase in lung cancer patients. Clin. Invest. 1992; 70: 307–319
  • Forrester L. M., Hayes J. D., Millis R., Barnes D., Harris A. L., Schlager J. J., Powis G., Wolf C. R. Expression of glutathione S-transferases and cytochrome P450 in normal and tumor breast tissue. Carcinogenesis 1990; 11: 2163–2170
  • Ranganathan S., Tew K. D. Immunohistochemical localization of glutathione S-transferases α, μ and ρ in normal tissue and carcinomas from human colon. Carcinogenesis 1991; 12: 2383–2387
  • Hayes P. C., May L., Hayes J. D., Harrison D. J. Glutathione S-transferases in human liver cancer. Gut 1991; 32: 1546–1549
  • Cairns J., Wright C., Cattan A. R., Hall A. G., Cantwell B. J., Harris A. L., Home C. H. W. Immunohistochemical demonstration of glutathione S-transferases in primary human breast carcinomas. J. Pathol. 1992; 166: 19–25
  • Fritz P., Behrle E., Beaune P., Eichelbaum M., Kroemer H. K. Differential expression of drug metabolizing enzymes in primary and secondary liver neoplasm: Immunohistochemical characterization of cytochrome P4503A and glutathione-S-transferase. Histochemistry 1993; 99: 443–451
  • Beckett G. J., Howie A. F., Hussey A. J., Hayes P. C., Miller W. R., Hayes J. D. Radioimmunoassay measurements of the human glutathione S-transferases. Glutathione S-Transferases and Drug Resistance, J. D. Hayes, C. B. Pickett, T. J. Mantle. Taylor and Francis. 1990; 399–408
  • Hayes P. C., Bouchier I. A. D., Beckett G. J. Glutathione S-transferase in humans in health and disease. Gut 1991; 32: 813–818
  • Howie A. F., Spencer E., Beckett G. J. Aspartate aminotransferase, alanine aminotransferase, and glutathione transferase in plasma during and after sedation by low-dose isoflurane or midazolam. Clin. Chem. 1992; 38: 476–479
  • Niitsu Y., Takahashi Y., Saito T., Hirata Y., Arisato N., Maruyama H., Kohgo Y., Listowsky I. Serum glutathione-S-tranS-ferase-ρ as a tumor marker for gastrointestinal malignancies. Cancer 1989; 63: 317–323
  • Niitsu Y., Ishigaki S., Takahashi Y., Hirata Y., Saito T., Arisato N., Hosoda K., Watanabe N., Kohgo Y. GST-ρ: assay for serodiagnosis of malignancy. Glutathione S-Transferases and Drug Resistance, J. D. Hayes, C. B. Pickett, T. J. Mantle. Taylor and Francis. 1990; 409–417
  • Tsuchida S., Sekine Y., Shineha R., Nishihira T., Sato K. Elevation of the placental glutathione 5-transferase from (GST-ρ) in tumor tissues and the levels in sera of patients with cancer. Cancer Res. 1989; 49: 5225–5229
  • Hirata S., Odajima T., Kohama G., Ishigaki S., Niitsu Y. Significance of glutathione S-transferase-ρ as a tumor marker in patients with oral cancer. Cancer 1992; 70: 2381–2387
  • te Koppele J. M., Schipper C., Breimer D. D., Mulder G. J. Stereoselectivity in the urinary excretion of the mercapturates of (R-)- and (S-)-α-bromoisovalerylurea in man. Br. J. Clin. Pharmacol. 1989; 28: 151–154
  • Mulders T. M. T., Breimer D. D., Mulder G. J. Glutathione conjugation in man. Human Drug Metabolism: From Molecular Biology to Man, E. H. Jeffrey. CRC Press, Boca Raton, FL 1992; 133–142
  • Mulders T. M. T., van Ommen B., van Bladeren P. J., Breimer D. D., Mulder G. J. Stereoselectivity of human liver and intestinal cytosolic fractions as well as purified glutathione 5-transferase isoenzymes towards 2-bromoisovalerylurea enantiomers. Bio-chem. Pharmacol. 1993; 46: 1775–1780
  • Waxman D. J. Glutathione S-Transferases: Role in alkylating agent resistance and possible target for modulation chemotherapy. A Review. Cancer Res. 1990; 50: 6449–6454
  • Ozols R. F., O'Dwyer P. J., Hamilton T. C., Young R. C. The role of glutathione in drug resistance. Cancer Treatment Rev. 1990; 17: 45–50
  • Glutathione S-Transferases and Drug Resistance, J. D. Hayes, C. B. Pickett, T. J. Mantle. Taylor and Francis, London 1990, pp.
  • Mistry P., Harrap K. R. Historical aspects of glutathione and cancer chemotherapy. Pharmac. Ther. 1991; 49: 125–132
  • Ciaccio P. J., Tew K. D. Glutathione S-transferases. Drug Resistance in Oncology, B. A. Teicher. Dekker, New York 1993; 351–374
  • Townsend A. J., Tu C. P. D., Cowan K. H. Expression of human μ or α class glutathione S-transferases in stable transfected human MCF-7 breast cancer cells: Effect on cellular sensitivity to cytotoxic agents. Mol. Pharmacol. 1992; 41: 230–236
  • Schecter R. L., Alaoui-Jamali M. A., Woo A., Fahl W. E., Batist G. Expression of a rat glutathione-S-transferase complementary DNA in rat mammary carcinoma cells: Impact upon alkylator-induced toxicity. Cancer Res. 1993; 53: 4900–4906
  • Hosking L. K., Whelan R. D. H., Shellard S. A., Bedford P., Hill B. T. An evaluation of the role of glutathione and its associated enzymes in the expression of differential sensitivities to anti-tumour agents shown by a range of human tumour cell lines. Bio-chem. Pharmacol 1990; 40: 1833–1842
  • Vincenzini M. T., Marraccini P., Iantomasi T., Favilli F., Pacini S., Ruggiero M. Altered metabolism of glutathione in cells transformed by oncogenes which cause resistance to ionizing radiations. FEBS Lett. 1993; 320: 219–223
  • Sladek N. E. Metabolism of oxazaphosphorines. Pharmac. Ther. 1989; 37: 301–355
  • Skinner R., Sharkey I. M., Pearson A. D. J., Craft A. W. Ifosfamide, mesna, and nephrotoxicity in children. J. Clin. Oncol. 1993; 11: 173–190
  • Lind M. J., McGown A. T., Hadfield J. A., Thatcher N., Crowther D., Fox B. W. The effect of ifosfamide and its metabolites on intracellular glutathione levels in vitro and in vivo. Biochem. Pharmacol. 1989; 38: 1835–1840
  • Peters R. H., Jollow D. J., Stuart R. K. Role of glutathione in the in vitro synergism between 4-hydroperoxycyclophosphamide and cisplatin in leukemia cell lines. Cancer Res. 1991; 51: 2536–2541
  • Berhane K., Mannervik B. Inactivation of the genotoxic aldehyde acrolein by human glutathione transferases of classes alpha, mu, and pi. Mol. Pharmacol. 1990; 37: 251–254
  • Yuan Z. M., Smith P. B., Brundrett R. B., Colvin M., Fenselau C. Glutathione conjugation with phosphoramide mustard and cyclophosphamide. A mechanistic study using tandem mass spectrometry. Drug Metab. Dispos. 1991; 19: 625–629
  • Dulik D. M., Fenselau C., Hilton J. Characterization of melphalan-glutathione adducts whose formation is catalyzed by glutathione transferases. Biochem. Pharmacol 1986; 35: 3405–3409
  • Bolton M. G., Colvin O. M., Hilton J. Specificity of isozymes of murine hepatic glutathione 5-transferase for the conjugation of glutathione with L-phenylalanine mustard. Cancer Res. 1991; 51: 2410–2415
  • Guenthner T. M., Whalen R., Jevtović-Todorović V. Direct measurement of melphalan conjugation with glutathione: Studies with human melanoma cells and mammalian liver. J. Pharmacol. Exp. Ther. 1992; 260: 1331–1336
  • Ciaccio P. J., Tew K. D., LaCreta F. P. Enzymatic conjugation of chlorambucil with glutathione by human glutathione S-transferases and inhibition by ethacrynic acid. Biochem. Pharmacol. 1991; 42: 1504–1507
  • Meyer D. J., Gilmore K. S., Harris J. M., Hartley J. A., Ketterer B. Chlorambucil-monoglutathionyl conjugate is sequestered by human alpha class glutathione S-transferases. Br. J. Cancer 1992; 66: 433–438
  • Smith M. T., Evans C. G., Doane-Setzer P., Castro V. M., Tahir M. K., Mannervik B. Denitrosation of 1,3-bis(2-chloroethyl)-1-nitrosourea by class mu glutathione transferases and its role in cellular resistance in rat brain tumor cells. Cancer Res. 1989; 49: 2621–2625
  • Berhane K., Hao X. Y., Egyházi S., Hansson J., Ringborg U., Mannervik B. Contribution of glutathione transferase M3–3 to 1,3-bis(2-chloroethyl)-1-nitrosourea resistance in a human non-small cell lung cancer cell line. Cancer Res. 1993; 53: 4257–4261
  • Mistry P., Kelland L. R., Abel G., Sidhar S., Harrap K. R. The relationships between glutathione, glutathione S-transferase and cytotoxicity of platinum drugs and melphalan in eight human ovarian cell lines. Br. J. Cancer 1991; 64: 215–220
  • Godwin A. K., Meister A., O'Dwyer P. J., Huang C. S., Hamilton T. C., Anderson M. E. High resistance to cisplatin in human ovarian cancer cell lines is associated with marked increase of glutathione synthesis. Proc. Natl. Acad. Sci. USA 1992; 89: 3070–3074
  • Meijer C., Mulder N. H., Timmer-Bosscha H., Sluiter W. J., Meersma G. J., de Vries E. G. E. Relationship of cellular glutathione to the cytotoxicity and resistance of seven platinum compounds. Cancer Res. 1992; 52: 6885–6889
  • Ishikawa T., Ali-Osman F. Glutathione-associated cis-diamminedichloroplatinum(II) metabolism and ATP-dependent efflux from leukemia cells. J. Biol. Chem. 1993; 268: 20116–20125
  • Lai G. M., Moscow J. A., Alvarez M. G., Fojo A. T., Bates S. E. Contribution of glutathione and glutathione-dependent enzymes in the reversal of adriamycin resistance in colon carcinoma cell lines. Int. J. Cancer 1991; 49: 688–695
  • Peters W. H. M., Roelofs H. M. J. Biochemical characterization of resistance to mitoxantrone and adriamycin in Caco-2 human colon adenocarcinoma cells: A possible role for glutathione S-transferases. Cancer Res. 1992; 52: 1886–1890
  • Ramachandran C., Yuan Z. K., Huang X. L., Krishan A. Doxorubicin resistance in human melanoma cells: MRD-1 and glutathione S-transferase ρ gene expression. Biochem. Pharmacol. 1993; 45: 743–751
  • Doroshow J. H., Akman S., Esworthy S., Chu F. F., Burke T. Doxorubicin resistance conferred by selective enhancement of intracellular glutathione peroxidase or superoxide distmutase content in human MCF-7 breast cancer cells. Free Rod. Res. Commun. 1991; 12–13, 779–781
  • Howie A. F., Forrester L. M., Glancey M. J., Schlager J. J., Powis G., Beckett G. J., Hayes J. D., Wolf C. R. Glutathione 5-transferase and glutathione peroxidase expression in normal and tumour human tissues. Carcinogenesis 1990; 11: 451–458
  • Ishioka C., Kanamaru R., Shibata H., Konishi Y., Ishikawa A., Wakui A., Sato T., Nishihira T. Expression of glutathione S-trans-ferase-ρ messenger RNA in human esophageal cancers. Cancer 1991; 67: 2560–2564
  • Peters W. H. M., Wormskamp N. G. M., Thies E. Expression of glutathione S-transferases in normal gastric mucosa and in gastric tumors. Carcinogenesis 1990; 11: 1593–1596
  • Redmond S. M. S., Joncourt F., Buser K., Ziemiecki A., Altermatt H. J., Fey M., Margison G., Cerny T. Assessment of P-glycoprotein, glutathione-based detoxifying enzymes and O6-alkyl-guanine-DNA alkyltransferase as potential indicators of constitutive drug resistance in human colorectal tumors. Cancer Res. 1991; 51: 2092–2097
  • Moscow J. A., Fairchild C. R., Madden M. J., Ransom D. T., Wieand H. S., O'Brien E. E., Poplack D. G., Cossman J., Myers C. E., Cowan K. H. Expression of anionic glutathione-5-trans-ferase and P-glycoprotein genes in human tissues and tumors. Cancer Res. 1989; 49: 1422–1428
  • Toffoli G., Viel A., Tumiotto L., Giannini F., Volpe R., Quaia M., Boiocchi M. Expression of glutathione S-transferase-ρ in human tumours. Eur. J. Cancer. 1992; 28A: 1441–1446
  • Peters W. H. M., Wobbes T., Roelofs H. M. J., Jansen J. B. M. J. Glutatione s-transferases in esophageal cancer. Carcinogenesis 1993; 14: 1377–1380
  • Hatton T., Pendleton N., Barraclough R., Green J. A. Expression of glutathione S-transferase (GST) subtypes in resected lung tumours: Relationship to histological type and proliferation indices. Int. J. Oncol. 1993; 3: 881–886
  • Eimoto H., Tsutsumi M., Nakajima A., Yamamoto K., Taka-shima Y., Maruyama H., Konishi Y. Expression of the glutathione S-transferase placental form in human lung carcinomas. Carcinogenesis 1988; 9: 2325–2327
  • Janot F., Massaad L., Ribrag V., de Waziers I., Beaune P. H., Luboinski B., Parise O., Gouyette A., Chabot G. C. Principal xenobiotic-metabolizing enzyme systems in human head and neck squamous cell carcinoma. Carinogenesis 1993; 14: 1279–1283
  • Lafuente A., Giralt M., Cervello I., Pujol F., Mallol J. Glu-tathione-5-transferase activity in human superficial transitional cell carcinoma of the bladder. Cancer 1990; 65: 2064–2068
  • Giralt M., Lafuente A., Pujol F., Mallol J. Enhanced gluata-thione S-transferase activity and glutathione content in human bladder cancer. Followup study: Influence of smoking. J. Urol. 1993; 149: 1452–1454
  • Perry R. R., Mazetta J., Levin M., Barranco S. C. Glutathione levels and variability in breast tumors and normal tissue. Cancer 1993; 72: 783–787
  • Gilbert L., Elwood L. J., Merino M., Masood S., Barnes R., Steinberg S. M., Lazarous D. F., Pierce L., d'Angelo T., Moscow J. A., Townsend A. J., Cowan K. H. A pilot study of pi-class glutathione S-transferase expression in breast cancer: correlation with estrogen receptor expression and prognosis in node-negative breast cancer. J. Clin. Oncol. 1993; 11: 49–58
  • Peters W. H. M., Roelofs H. M. J., van Putten W. L. J., Jansen J. B. M. J., Klijn J. G. M., Foekens J. A. Response to adjuvant chemotherapy in primary breast cancer: No correlation with expression of gluathione S-transferases. Br. J. Cancer 1993; 68: 86–92
  • Murphy D., McGown A. T., Hall A., Cattan A., Crowther D., Fox B. W. Glutathione S-transferase activity and isoenzyme distribution in ovarian tumour biopsies before or after cytotoxic chemotherapy. Br. J. Cancer 1992; 66: 937–942
  • van der Zee A. G. J., van Ommen B., Meijer C., Hollema H., van Bladeren P. J., de Vries E. G. E. Glutathione S-transferase activity and isoenzyme composition in benign ovarian tumours, untreated malignant ovarian tumours, and malignant ovarian tumours after platinum/cyclophosphamide chemotherapy. Br. J. Cancer 1992; 66: 930–936
  • Cook J. A., Pass H. I., Iype S. N., Friedman N., DeGraff W., Russo A., Mitchell J. B. Cellular glutathione and thiol measurements from surgically resected human lung tumor and normal lung tissue. Cancer Res. 1991; 51: 4287–4294
  • Kihara M., Kihara M., Noda K., Okamoto N. Increased risk of lung cancer in Japanese smokers with class mu glutathione 5-transferase gene deficiency. Cancer Lett. 1993; 71: 151–155
  • Lafuente A., Pujol F., Carretero P., Villa J. P., Cuchi A. Human glutathione S-transferase μ (GSTμ) deficiency as a marker for the susceptibility to bladder and larynx cancer among smokers. Cancer Lett. 1993; 68: 49–54
  • van Poppel G., de Vogel N., van Bladeren P. J., Kok F. J. Increased cytogenetic damage in smokers deficient in glutathione S-transferase isoenzyme μ. Carcinogenesis 1992; 13: 303–305
  • Nakachi K., Imai K., Hayashi S., Kawajiri K. Polymorphism of the CYP1A1 and glutathione S-transferase genes associated with susceptibility to lung cancer in relation to cigarette dose in a Japanese population. Cancer Res. 1993; 53: 2994–2999
  • Wolf C. R., Macpherson J. S., Smyth J. F. Evidence for the metabolism of mitozantrone by microsomal glutathione transferases and 3-methylcholantrene-inducible glucuronosyl transferases. Bio-chem. Pharmacol 1986; 35: 1577–1581
  • Wright C., Cairns J., Cantwell B. J., Cattan A. R., Hall A. G., Harris A. L., Home C. H. W. Response to mitoxantrone in advanced breast cancer: Correlation with expression of c-erbB-2 protein and glutathione 5-transferases. Br. J. Cancer 1992; 65: 271–274
  • Toffoli G., Frustaci S., Tumiotto L., Talamini R., Gherlinzoni F., Picci P., Boiocchi M. Expression of MDR1 and GST-ρ in human soft tissue sarcomas: Relation to drug resistance and biological aggressiveness. Ann. Oncol. 1992; 3: 63–69
  • Britten R. A., Green J. A., Warenius H. M. Cellular glutathione (GSH) and glutathione 5-transferase (GST) activity in human ovarian tumor biopsies following exposure to alkylating agents. Int. J. Radial. Oncol. Biol. Phys. 1992; 24: 527–531
  • Tanita J., Tsuchida S., Hozawa J., Sato K. Expression of glutathione S-transferase-rc in human squamous cell carcinomas of the pharynx and larynx. Cancer 1993; 72: 569–576
  • Tidefelt U., Elmhorn-Rosenborg A., Paul C., Hao X. Y., Mannervik B., Eriksson L. C. Expression of glutathione transferase ρ as a predictor for treatment results at different stages of acute nonlymphoblastic leukemia. Cancer Res. 1992; 52: 3281–3285
  • Rodriguez C., Commes T., Robert J., Rossi J. F. Expression of p-glycoprotein and anionic glutathione S-transferase genes in non-Hodgkin's lymphoma. Leukemia Res. 1993; 17: 149–156
  • Shi E. C. P., Fisher R., McEvoy M., Vantol R., Rose M., Ham J. M. Factors influencing hepatic glutathione concentrations: A study in surgical patients. Clin. Sci. 1982; 62: 279–283
  • Israël Y., Speisky H., Lanç A. J., Iwamura S., Hirai M., Varghese G. Metabolism of hepatic glutathione and its relevance in alcohol induced liver damage. Cell. Mol. Aspects Cirrhosis 1992; 216: 25–37
  • Hercbergs A., Brok-Simoni F., Holtzman F., Bar-Am J., Leith J. T., Brenner H. J. Erythrocyte glutathione and tumour response to chemotherapy. Lancet 1992; 339: 1074–1076
  • Meister A. On the antioxidant effects of ascorbic acid and glutathione. Biochem. Pharmacol. 1992; 44: 1905–1915
  • Henning S. M., Zhang J. Z., McKee R. W., Swendseid M. E., Jacob R. A. Glutathione blood levels and other oxidant defense indices in men fed diets low in vitamin C. J. Nutr. 1991; 121: 1969–1975
  • Johnston C. S., Meyer C. G., Srilakshmi J. C. Vitamin C elevates red blood cell glutathione in healthy adults. Am. J. Clin. Nutr. 1993; 58: 103–105
  • Beckett G. J., Kellett H. A., Gow S. M., Hussey A. J., Hayes J. D., Toft A. D. Raised plasma glutathione S-transferase values in hyperthyroidism and in hypotheroid patients receiving thyroxine replacement: Evidence for hepatic damage. Br. Med. J. 1985; 291: 427–431
  • Sir T., Wolff C., Soto J. R., Perez G., Merino R. A. Relationship between hepatic levels of glutathione and sulphobromo-phthalein retention in hyperthyroidism. Clin. Sci. 1987; 73: 235–237
  • Fernandez V., Simizu K., Barros S. B. M., Azzalis L. A., Pimentel R., Junqueira V. B. C., Videla L. A. Effects of hyperthyroidism on rat liver glutathione metabolism: Related enzymes' activities, efflux, and turnover. Endocrinology 1991; 129: 85–91
  • Lauterburg B. H., Velez M. E. Glutathione deficiency in alcoholics: Risk factor for paracetamol hepatotoxicity. Gut 1988; 29: 1153–1157
  • Ji L. L., Katz A., Fu R., Griffiths M., Spencer M. Blood glutathione status during exercise: Effect of carbohydrate supplementation. J. Appl. Physiol. 1993; 74: 788–792
  • Lang C. A., Naryshkin S., Schneider D. L., Mills B. J., Lindeman R. D. Low blood glutathione levels in healthy aging adults. J. Lab. Clin. Med. 1992; 120: 720–725
  • Richie J. P. The role of glutathione in aging and cancer. Exp. Gerontol. 1992; 27: 615–626
  • Smaaland R., Abrahamsen J. F., Svardal A. M., Lote K., Ueland P. M. DNA cell cycle distribution and glutathione (GSH) content according to circadian stage in bone marrow of cancer patients. Br. J. Cancer 1992; 66: 39–45
  • Smaaland R., Svardal A. M., Lote K., Ueland P. M., Laerum O. D. Glutathione content in human bone marrow and circadian stage relation to DNA synthesis. J. Natl. Cancer Inst. 1991; 83: 1092–1098
  • Meister A. A trial of research: From glutamine synthetase to selective inhibition of glutathione synthesis. Chemtracts–Biochem. Mol. Biol. 1992; 3: 75–106
  • LaCreta F., Brennan J., Padavic K., Hamilton T., Tew K., Young R., Comis R., Ozols R., O'Dwyer P. Phase I clinical, biochemical and pharmacokinetic study of buthionine sulfoximine (BSO) in combination with melphalan (L-PAM),. Proc. Am. Soc. Clin. Oncol. 1991; 10: 285
  • O'Dwyer P. J., Hamilton T. C., Young R. C., LaCreta F. P., Carp N., Tew K. D., Padavic K., Comis R. L., Ozols R. F. Depletion of glutathione in normal and malignant cells in vivo by buthionine sulfoximine: Clinical and biochemical results. J. Natl. Cancer Inst. 1992; 84: 264–267
  • Bailey H., Mulcahy R. T., Tutsch K. D., Arzoomanian R. Z., Alberti D., Feierabend C., Tombes M. B., Wilding G., Spriggs D. Phase I trial of intravenous melphalan (L-PAM) and L-buthionine sulfoximine (BSO): An attempt at modulation of glutathione (GSH) chemoprotection,. Proc. Am. Soc. Clin. Oncol. 1992; 11: 278
  • Yao K. S., Godwin A. K., Ozols R. F., Hamilton T. C., O'Dwyer P. J. Variable baseline y-glutamylcysteine synthetase messenger RNA expression in peripheral mononuclear cells of cancer patients, and its induction by buthionine sulfoximine treatment. Cancer Res. 1993; 53: 3662–3666
  • Uhlig S., Wendel A. The physiological consequences of glutathione variations. Life Sci. 1992; 51: 1083–1094
  • Polhuijs M., Lankhaar G., Mulder G. J. Relationship between glutathione content in liver and glutathione conjugation rate in the rat in vivo. Biochem. J. 1992; 285: 401–404
  • Meister A. Depletion of glutathione in normal and malignant human cells in vivo by L-buthionine sulfoximine: Possible interaction with ascorbate. J. Natl. Cancer Inst. 1992; 84: 1601–1602
  • Witschi A., Reddy S., Stofer B., Lauterburg B. H. The systemic availability of oral glutathione. Eur. J. Clin. Pharmacol. 1992; 43: 667–669
  • Aw T. Y., Wierzbicka G., Jones D. P. Oral glutathione increases tissue glutathione in vivo. Chem.-Biol. Interact. 1991; 80: 89–97
  • Di Re F., Bohm S., Oriana S., Spatti G. B., Pirovano M., Tedeschi M., Zunino F. High-dose cisplatin and cyclophosphamide with glutathione in the treatment of advanced ovarian cancer. Ann. Oncol. 1993; 4: 55–61
  • Hamers F. P. T., Brakkee J. H., Cavalletti E., Tedeschi M., Marmonti L., Pezzoni G., Neijt J. P., Gispen W. H. Reduced glutathione protects against cisplatin-induced neurotoxicity in rats. Cancer Res. 1993; 53: 544–549
  • O'Dwyer P. J., LaCreta F., Nash S., Tinsley P. W., Schilder R., Clapper M. L., Tew K. D., Panting L., Litwin S., Comis R. L., Ozols R. F. Phase I study of thiotepa in combination with the glutathione transferase inhibitor ethacrynic acid. Cancer Res. 1991; 51: 6059–6065
  • Kuzmich S., Vanderveer L. A., Walsh E. S., LaCreta F. P., Tew K. D. Increased levels of glutathione 5-transferase ρ transcript as a mechanism of resistance to ethacrynic acid. Biochem. J. 1992; 281: 219–224

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.